Many people notice appetite suppression strengthening gradually over weeks, confirming that the starting dose is engaging receptors even when the scale is not moving dramatically
These medications intended for diabetes and weight loss can help addiction without the associated stigma, which will be a new window for how to deal with addiction. The protective effects were consistent and even applied to people with Type 2 diabetes, obesity, or both conditions
Phase 2 trial data showed average weight loss of up to 24.2% at 48 weeks, while the newer Phase 3 trial data showed 28.7% average weight loss at 68 weeks on the 12mg dose
It is not recommended as a first-line therapy in BED, although modest weight loss may confer secondary psychological benefit [142]
Plain yogurt with live cultures may help by supporting beneficial gut bacteria during the microbiome disruption that GLP-1 agonists can cause
Kathy Hochul signed a spree of healthcare bills into law this month